HKU Scholars Hub: Browsing DSpace

Browsing by Author Mangia, A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 2 to 5 of 5 < previous

	Title	Author(s)	Issue Date	Views
	IFN-lambda3, not IFN-lambda4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis Journal:Nat Genet	Eslam, M McLeod, D Kelaeng, KS Mangia, A Berg, T Thabet, K Irving, WL Dore, GJ Sheridan, D Gronbaek, H Abate, ML Hartmann, R Bugianesi, E Spengler, U Rojas, A Booth, DR Weltman, M Mollison, L Cheng, W Riordan, S Mahajan, H Fischer, J Nattermann, J Douglas, MW Liddle, C Powell, E Romero-Gomez, M George, J International Liver Disease Genetics, C Leung, CMR	2017	36
	MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C Journal:Nature Communications	Thabet, K Asimakopoulos, A Shojaei, M Romero-Gomez, M Mangia, A Irving, WL Berg, T Dore, GJ Gronbaek, H Sheridan, D Abate, ML Bugianesi, E Weltman, M Mollison, L Cheng, W Riordan, S Fischer, J Spengler, U Nattermann, J Wahid, A Rojas, A White, R Douglas, MW McLeod, D Powell, E Liddle, C van der Poorten, D George, J Eslam, M International Liver Disease Genetics, C Leung, CMR	2016	47
	Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection Journal:New England Journal of Medicine	Feld, JJ Jacobson, IM Hézode, C Asselah, T Ruane, PJ Gruener, N Abergel, A Mangia, A Lai, CL Chan, HLY Mazzotta, F Moreno, C Yoshida, E Shafran, SD Towner, WJ Tran, TT McNally, J Osinusi, A Svarovskaia, E Zhu, Y Brainard, DM McHutchison, JG Agarwal, K Zeuzem, S	2015	110
	Sofosbuvir/velpatasvir (SOF/VEL) for 12 weeks in genotype 1, 2, 4, 5, 6 HCV patients: ASTRAL-1 study Proceeding/Conference:Hepatology International	Chan, HLY Feld, JJ Agarwal, K Hezode, C Asselah, T Ruane, PJ Gruener, N Abergel, A Mangia, A Lai, CL Mazzotta, F Moreno, C Yoshida, E Shafran, SD Towner, WJ Tran, TT McNally, J Brainard, DM Jacobson, IM Zeuzem, S	2016	68

Showing results 2 to 5 of 5 < previous